129 related articles for article (PubMed ID: 50291)
1. Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants?
Klein G; Klein E
Int J Cancer; 1975 Jun; 15(6):879-87. PubMed ID: 50291
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated antigens in H-2 hemizygous isoantigenic variants of a somatic cell hybrid, derived from the fusion of a 3-methylcholanthrene-induced sarcoma and a mammary carcinoma.
Klein G
J Natl Cancer Inst; 1977 Feb; 58(2):383-6. PubMed ID: 833884
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic studies on the mechanism of formation of isoantigenic variants in somatic cell hybrids. I. Banding analyses of isoantigenic variant sublines derived from the fusion of TA3Ha carcinoma with MSWBS sarcoma cells.
Wiener F; Dalianis T; Klein G; Harris H
J Natl Cancer Inst; 1974 Jun; 52(6):1779-96. PubMed ID: 4834408
[No Abstract] [Full Text] [Related]
4. Role of H-2 antigens in the host response to methylcholanthrene-induced tumors.
Ahrlund-Richter L; Klein E; Merino F
Immunogenetics; 1982 Jan; 15(1):53-62. PubMed ID: 6979509
[TBL] [Abstract][Full Text] [Related]
5. Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas.
Hellström KE; Hellström I; Brown JP
Int J Cancer; 1978 Mar; 21(3):317-22. PubMed ID: 75855
[TBL] [Abstract][Full Text] [Related]
6. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
Parmiani G; Invernizzi G
Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
[TBL] [Abstract][Full Text] [Related]
7. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
Chauvenet PH; Smith RT
Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
[TBL] [Abstract][Full Text] [Related]
8. Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma.
Natori T; Law LW; Appella E
Cancer Res; 1977 Sep; 37(9):3406-13. PubMed ID: 69494
[TBL] [Abstract][Full Text] [Related]
9. Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcoma.
Parmiani G; Colombo M; Ballinari D
Int J Cancer; 1980 Oct; 26(4):461-5. PubMed ID: 7251224
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of morphological differentiation in a lymphoma-sarcoma hybrid.
Cochran AL; Harris H; Wiener F; Klein G
J Pathol; 1975 Jan; 115(1):1-12. PubMed ID: 1151512
[TBL] [Abstract][Full Text] [Related]
11. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
Law LW
Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
[TBL] [Abstract][Full Text] [Related]
12. Cells from chemically induced mouse sarcomas retain tumor-specific transplantation antigenicity during prolonged passage in vitro.
Walker R; Hellström I; Hellström KE
Int J Cancer; 1980 Mar; 25(3):345-8. PubMed ID: 7390657
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated antigens in isoantigenic variants of a 3-methylcholanthrene-induced sarcoma.
Oth D; Berebbi M; Meyer G
J Natl Cancer Inst; 1975 Oct; 55(4):903-8. PubMed ID: 52721
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
Pellis NR; Tom BH; Kahan BD
J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
[No Abstract] [Full Text] [Related]
15. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
Leffell MS; Coggin JH
Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
[No Abstract] [Full Text] [Related]
16. Partial purification of tumour-specific transplantation antigens from methylcholanthrene-induced murine sarcomas by immobilized lectins.
Sikora K; Koch G; Brenner S; Lennox E
Br J Cancer; 1979 Dec; 40(6):831-8. PubMed ID: 93484
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
Kahan BD; Tanaka T; Pellis NR
J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
[TBL] [Abstract][Full Text] [Related]
18. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
19. Correspondence re: Mary S. Leffell and Joseph H. Coggin, Jr. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection. Cancer Res., 37: 4112--4119, 1977.
Basombrio MA
Cancer Res; 1978 Oct; 38(10):3568-9. PubMed ID: 80267
[No Abstract] [Full Text] [Related]
20. Selective reaction of effector lymphocytes of transplantation immunity to private specificities of the H-2K and H-2D loci.
Brondz BD; Egorov IK
Bull Exp Biol Med; 1974 Dec; 77(6):659-62. PubMed ID: 4140743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
